Provided by Tiger Trade Technology Pte. Ltd.

IMMUNEONCO-B

3.710
0.000
Volume:1.31M
Turnover:5.01M
Market Cap:1.59B
PE:-6.00
High:3.930
Open:3.700
Low:3.700
Close:3.710
52wk High:16.800
52wk Low:2.800
Shares:429.00M
HK Float Shares:418.00M
Volume Ratio:1.41
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.618
ROE:-40.11%
ROA:-16.24%
PB:2.18
PE(LYR):-6.00
PS:10.83

Loading ...

ImmuneOnco unit Jiaxing Changxin subscribes RMB 325,000 in subsidiary, takes 20% stake

Reuters
·
Jun 18

ImmuneOnco Biopharm Invests HK$88 Million in Wealth Management Product

MT Newswires Live
·
Jun 18

IMMUNEONCO-B Invests HK$87.5 Million in Financial Product

Stock News
·
Jun 17

ImmuneOnco Biopharmaceuticals (Shanghai) - to Subscribe for Wealth Management Product for HK$87.5 Mln From Vital Ventures

THOMSON REUTERS
·
Jun 17

IMMUNEONCO-B Executes Share Buyback, Spending HK$592,500 on June 16

Stock News
·
Jun 16

ImmuneOnco files HKEX next-day disclosure return on share repurchase for treasury shares at HKD 3.63

Reuters
·
Jun 16

ImmuneOnco Repurchases 2,600 H-Shares, Lifts Treasury Stock to 0.18% of Mandate Capacity

Bulletin Express
·
Jun 12

IMMUNEONCO-B Executes Share Buyback Transaction on June 12

Stock News
·
Jun 12

ImmuneOnco files HKEX next-day disclosure return on share repurchase for cancellation

Reuters
·
Jun 11

IMMUNEONCO-B trims float with HKD 0.17 million repurchase of 52,800 H shares

Bulletin Express
·
Jun 10

IMMUNEONCO-B Repurchases 52.8K Shares for HK$169.3K on June 10

Stock News
·
Jun 10

ImmuneOnco Executes HKD 1.29 Million Share Buyback, Trimming Free Float by 0.10%

Bulletin Express
·
Jun 09

IMMUNEONCO-B repurchases 0.06% of H-share float for HKD 0.83 million

Bulletin Express
·
Jun 08

IMMUNEONCO-B Executes Share Buyback, Spending HK$827,800

Stock News
·
Jun 08

ImmuneOnco Biopharmaceuticals (Shanghai) - to Repurchase H Shares in Open Market

THOMSON REUTERS
·
Jun 08

Asian Market Insights: ImmuneOnco Biopharmaceuticals (Shanghai) Among 3 Promising Penny Stocks

Simply Wall St.
·
Jun 08

IMMUNEONCO-B Shares Surge Over 7% on Positive Early Trial Data for SLE Drug Candidate

Stock News
·
Jun 05

ImmuneOnco Biopharmaceuticals Reports No Change in Share Capital for May 2026

Bulletin Express
·
Jun 03

Hong Kong Stock Surge: IMMUNEONCO-B Soars Over 7% on Positive IMM2510 Data for IO-Refractory Lung Cancer

Stock News
·
Jun 02

IMMUNEONCO-B AGM Endorses 2025 Financials, Reappoints Deloitte and Renews Dual Mandates

Bulletin Express
·
May 28